When testing new treatments, drugmakers must show that their formulation bears out better results than a placebo in clinical trials. In fact, the new drug must outperform the placebo by a ...

As we enter 2026, the S&P 500 stands at a historically high valuation. Models suggest that smaller and international stocks ...

The benchmark S&P 500 lost 10.5% of its value from April 3 through April 4, which is the fifth-steepest two-day decline since 1950. Tariff-related uncertainty, coupled with the stock market entering ...

International value stocks have underperformed US counterparts for over a decade. But after DFIV’s 47% surge this past year, ...

Spanning 16 trading sessions (Feb. 19 through Mar. 13), the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite respectively fell by 8.6%, 10.1%, and 13.7%. Uncertainty regarding President ...

The widely followed Standard & Poor’s 500 Index is the standard by which stock market performance in the U.S. is often measured, as it tracks 500 of the largest and most stable publicly traded ...

Capital at risk. The value of your investments can go up and down, and you may get back less than you invest. Any discussion about investing in shares will, sooner or later, mention their ‘price ...